Quantum Pharma Consulting Limited 06703987 false 2022-10-01 2023-09-30 2023-09-30 The principal activity of the company is recruitment consultancy Digita Accounts Production Advanced 6.30.9574.0 true 06703987 2022-10-01 2023-09-30 06703987 2023-09-30 06703987 bus:Original 2023-09-30 06703987 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 06703987 core:Non-currentFinancialInstruments core:AfterOneYear 2023-09-30 06703987 bus:Micro-entities 2022-10-01 2023-09-30 06703987 bus:AuditExemptWithAccountantsReport 2022-10-01 2023-09-30 06703987 bus:FullAccounts 2022-10-01 2023-09-30 06703987 bus:SmallCompaniesRegimeForAccounts 2022-10-01 2023-09-30 06703987 bus:RegisteredOffice 2022-10-01 2023-09-30 06703987 bus:CompanySecretary1 2022-10-01 2023-09-30 06703987 bus:Director1 2022-10-01 2023-09-30 06703987 bus:PrivateLimitedCompanyLtd 2022-10-01 2023-09-30 06703987 bus:Agent1 2022-10-01 2023-09-30 06703987 countries:AllCountries 2022-10-01 2023-09-30 06703987 2021-10-01 2022-09-30 06703987 2022-09-30 06703987 core:CurrentFinancialInstruments core:WithinOneYear 2022-09-30 06703987 core:Non-currentFinancialInstruments core:AfterOneYear 2022-09-30 iso4217:GBP xbrli:pure

Registration number: 06703987

Quantum Pharma Consulting Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 September 2023

 

Quantum Pharma Consulting Limited

Contents

Company Information

1

Accountants' Report

2

Statement of Financial Position

3

Notes to the Unaudited Financial Statements

4

 

Quantum Pharma Consulting Limited

Company Information

Director

Ms B Patel

Company secretary

Norika Patel

Registered office

2 Limes Close
Redhill
Surrey
RH1 5GT

Accountants

DSK Partners LLP
Chartered Accountants
163 Herne Hill
London
SE24 9LR

 

Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
Quantum Pharma Consulting Limited
for the Year Ended 30 September 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Quantum Pharma Consulting Limited for the year ended 30 September 2023 as set out on pages 3 to 4 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Quantum Pharma Consulting Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Quantum Pharma Consulting Limited and state those matters that we have agreed to state to the Board of Directors of Quantum Pharma Consulting Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Quantum Pharma Consulting Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Quantum Pharma Consulting Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and loss of Quantum Pharma Consulting Limited. You consider that Quantum Pharma Consulting Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Quantum Pharma Consulting Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

DSK Partners LLP
Chartered Accountants
163 Herne Hill
London
SE24 9LR

19 February 2024

 

Quantum Pharma Consulting Limited

(Registration number: 06703987)
Statement of Financial Position as at 30 September 2023

2023
£

2022
£

Fixed assets

1,424

160

Current assets

3,910

9,251

Creditors: Amounts falling due within one year

(17,710)

(6,009)

Net current (liabilities)/assets

(13,800)

3,242

Total assets less current liabilities

(12,376)

3,402

Creditors: Amounts falling due after more than one year

(6,901)

(8,487)

Accruals and deferred income

(1,385)

(1,352)

 

(20,662)

(6,437)

Capital and reserves

(20,662)

(6,437)

For the financial year ending 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the director on 19 February 2024
 


Ms B Patel
Director

 

Quantum Pharma Consulting Limited

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
2 Limes Close
Redhill
Surrey
RH1 5GT

The presentation currency of the financial statements is Pound Sterling (£) rounded to the nearest Pound.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).